International Council for Harmonisation (ICH)

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global organization dedicated to promoting harmonized pharmaceutical regulatory standards worldwide. Established in 1990 and headquartered in Geneva, Switzerland, ICH brings together regulatory authorities and pharmaceutical industry organizations to develop internationally recognized guidelines for medicine development and approval.

ICH develops technical guidelines that support the quality, safety, and effectiveness of pharmaceutical products throughout their lifecycle. These guidelines cover areas including clinical trials, pharmaceutical quality, safety assessment, efficacy evaluation, pharmacovigilance, and regulatory documentation.

The organization plays a critical role in improving global pharmaceutical development by reducing regulatory differences between countries and encouraging consistent scientific standards. Its guidelines are widely adopted by regulatory agencies and pharmaceutical companies around the world.

ICH works with major regulatory authorities including the U.S. FDA, European Medicines Agency (EMA), Japan’s PMDA, Health Canada, Swissmedic, and other global healthcare regulators. It also collaborates with pharmaceutical industry associations and scientific organizations.

The organization supports innovation in healthcare by providing frameworks for developing new medicines, biologics, advanced therapies, and emerging healthcare technologies.

ICH guidelines such as Good Clinical Practice (GCP) are considered global standards for conducting ethical and scientifically reliable clinical trials.

Through international cooperation and scientific consensus, ICH helps improve regulatory efficiency, supports pharmaceutical innovation, and contributes to the availability of safe and effective medicines for patients worldwide.